| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |